Ignite Creation Date:
2024-05-06 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 2:30 PM
Study NCT ID:
NCT05340413
Status:
RECRUITING
Last Update Posted:
2023-04-18
First Post:
2022-01-25
Brief Title:
Predicting Olaparib Sensitivity in Patients With Unresectable Locally AdvancedMetastatic HER2-negative Breast Cancer
Sponsor:
SOLTI Breast Cancer Research Group
Organization:
SOLTI Breast Cancer Research Group
Organization Data
Organization:
SOLTI Breast Cancer Research Group
Class:
OTHER
Study ID:
SOLTI-1910
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
SOLTI Breast Cancer Research Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None